Karen L. Smith, Director at ACCELERON PHARMA INC (XLRN), sold 17,850 shares at $137.92 ($2.4M) on 2021-04-01, disclosed to the SEC on 2021-04-02.
Open-market sale of $2.4M XLRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.54 | 1,201 | $162K | 6.6% |
| 2 | $134.54 | 1,201 | $162K | 6.6% |
| 3 | $136.22 | 2,987 | $407K | 16.7% |
| 4 | $136.22 | 2,987 | $407K | 16.7% |
| 5 | $136.92 | 3,796 | $520K | 21.3% |
| 6 | $136.92 | 3,796 |
| $520K |
| 21.3% |
| 7 | $137.92 | 941 | $130K | 5.3% |
| 8 | $137.92 | 941 | $130K | 5.3% |
| Total | $136.47 avg | 17,850 | $2.4M | 100% |
| Filing → |
| JAZZ | BUY | 2016-08-12 | $167K | — | Filing → |
| JAZZ | BUY | 2016-07-13 | $167K | — | Filing → |
| JAZZ | BUY | 2016-06-15 | $167K | — | Filing → |